British Journal of Pharmacology

Br J Pharmacol

0007-1188

1476-5381

Therapeutic Area

Pharmacology, Pharmacy

Biologists, Clinicians, Medicinal Chemists, Molecular Biologists, Neuroscientists, Pharmacists, Pharmacologists, Physicians, Physiologists, Researchers, Toxicologists

The British Journal of Pharmacology is a biomedical science journal giving leading international coverage of all aspects of experimental and translational pharmacology. The journal publishes high-quality original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor and commentaries. Review articles, databases, systematic reviews, and meta-analyses are normally commissioned, but consideration will be given to unsolicited contributions. These papers can be standalone or part of a themed issue. BJP also publishes the Concise Guide to Pharmacology, which is a snapshot in time of the BPS/IUPHAR Guide to Pharmacology database and published biennially. Commentaries are invited by the Editor-in-Chief and the Senior Editors on articles published in the journal. Letters to the Editor are acceptable where they are a comment on a paper recently published in the journal and relate to current issues pertinent to the field of pharmacology. In addition to basic science research, BJP publishes translational pharmacology research which includes proof-of-concept and early mechanistic studies in humans. BJP does not generally, except for in exceptional circumstances, publish first in man phase I for new molecular entities, phase IIb, III or IV studies unless the results are combined with results from preclinical studies. BJP publishes work on the actions of biological extracts, but only if the extract has known chemical composition (e.g. purified and validated) and known concentration. Papers that involve investigations on tobacco, smoking, alcohol, cocaine and other substances of abuse, whether directly or in the context of their use to generate a disease model (e.g. smoking for pulmonary disease), will be considered on scientific merit (which includes ethical justification) and relevance to pharmacology. BJP is committed to enhance research openness and reproducibility, by adhering to the Transparency and Openness Promotion (TOP) Guidelines, and publishes the journal performance on this metric annually. Click here to learn more about the policies BJP has already implemented.

British Pharmacological Society (BPS)

Wiley-Blackwell

Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines